대표적인 구강 및 비강 세정제의 Coronavirus Disease 2019 (COVID-19) 적용 연구의 현황
Current Status of the Use of Oral and Nasal Antiseptics during the Coronavirus Disease 2019 (COVID-19) Pandemic
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCI
- 저널 순위
- KCI Q4
- 저널
- 임상이비인후과32(3) · pp.170 · 2021
- 피인용
- KCI 1
- ISSN
- 1225-0244
저자
초록
This report provides the available evidence of the use of mouthwash and nasal irrigation with antiseptics to in- activate or eradicate severe, acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The oral cavity and nasal cavity are essential part of the upper airway tract, and are considered to play an important role in the pathoge- nicity and transmission of SARS-CoV-2. Angiotensin converting enzyme 2, cellular receptor for SARS-CoV-2, is found to highly expressed in the oral cavity and nasal cavity. Because there have been no approved treatment for coronavirus disease 2019 (COVID-19), considering mouthwash and nasal irrigation with the agents that can alleviate the viral load is an extremely simple and feasible strategy to prevent progression and transmission of COVID-19. Although sufficient in-vitro studies identified the efficacy of mouthwash and nasal irrigation, in-vivo evidence is still limited. Currently, there are many clinical trials to elucidate the efficacy of mouthwash and na- sal irrigation with variable agents. This effort will reduce the pathogenicity and the transmission of COVID-19 through the simple mouthwash and nasal irrigation.
키워드
식별자
- KCI
- ART002799792



로그인
연구물 목록으로